First Look Analyst Calls Briefing for Friday, November 18, 2022
Here's our earliest look at analysts' research calls for Friday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Equity Residential (EQR) upgraded to Buy from Hold at Argus; tgt $72
> ISS A/S (ISSDY) upgraded to Equal-Weight from Underweight at Morgan Stanley
> Matson (MATX) upgraded to Peer Perform from Underperform at Wolfe Research
> Verbund AG (OEZVY) upgraded to Buy from Hold at Societe Generale
> XPeng (XPEV) upgraded to Buy from Neutral at UBS; tgt lowered to $13
Downgrades:
> Cadence Bank (CADE) downgraded to Neutral from Buy at Janney; tgt raised to $30
> Descartes (DSGX) downgraded to Peer Perform from Outperform at Wolfe Research
> Dominion Energy (D) downgraded to In-line from Outperform at Evercore ISI; tgt $78
> Hub Group (HUBG) downgraded to Peer Perform from Outperform at Wolfe Research
> NIO (NIO) downgraded to Neutral from Buy at UBS; tgt lowered to $13
> Norfolk Southern (NSC) downgraded to Peer Perform from Outperform at Wolfe Research
> On (ONON) downgraded to Hold from Buy at Williams Trading; tgt $20
> PACCAR (PCAR) downgraded to Peer Perform from Outperform at Wolfe Research
> Saia (SAIA) downgraded to Peer Perform from Outperform at Wolfe Research
> Salesforce (CRM) downgraded to Neutral from Buy at Monness Crespi & Hardt
> Sprouts Farmers Market (SFM) downgraded to Neutral from Buy at Northcoast
Others:
> Franklin Covey (FC) initiated with an Outperform at Northland Capital; tgt $100
> Lemonade (LMND) initiated with a Mkt Perform at Keefe Bruyette; tgt $24
> Ventyx Biosciences (VTYX) initiated with an Overweight at Morgan Stanley; tgt $45
Contact [email protected] for any questions or corrections.